Xconomy Seattle

Omeros Corporation Garners $68,200,000 New Funding

  • Feed Type
  • Date
    10/8/2009
  • Company Name
    Omeros Corporation
  • Mailing Address
    1420 Fifth Avenue Seattle, WA 98101
  • Company Description
    Omeros recognized that a combination of agents acting on multiple molecular targets may be required for optimal therapeutic effect. Omeros’ product candidates are designed to modulate the molecular mechanisms of pathologic conditions rather than just treating their symptoms.
  • Website
    http://www.omeros.com
  • Transaction Type
    IPO
  • Transaction Amount
    $68,200,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes from the IPO are on file with the company statements at the SEC.
  • M&A Terms

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.